US Patent Application 18251129. CRYSTALLINE FORM III OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD THEREFOR simplified abstract
Jump to navigation
Jump to search
Contents
CRYSTALLINE FORM III OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD THEREFOR
Organization Name
Inventor(s)
CRYSTALLINE FORM III OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD THEREFOR - A simplified explanation of the abstract
This abstract first appeared for US patent application 18251129 titled 'CRYSTALLINE FORM III OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD THEREFOR
Simplified Explanation
The patent application is for a new crystalline form (Form III) of a compound represented by formula 1.
- The invention also includes a method for preparing the crystalline form III and a pharmaceutical composition containing it.
- The crystalline form III can be identified by its XRD patterns, DSC profiles, and/or TGA profiles.
- This new form of the compound may have unique properties or advantages compared to other forms, making it potentially useful in pharmaceutical applications.
Original Abstract Submitted
The present invention relates to a crystalline form III represented by formula 1, a method for preparing the same, and a pharmaceutical composition comprising the same. The crystalline form III represented by formula 1 of the present invention may be characterized by XRD patterns, DSC profiles, and/or TGA profiles.
